Skip to content

Neuroendocrine Mechanisms of Acupuncture in the Treatment of Hypertension

Zhou & Longhurst · Evidence-Based Complementary and Alternative Medicine · 2012

📚Narrative Review🧠Neural Mechanisms🎯High Impact

Evidence Level

STRONG
85/ 100
Quality
4/5
Sample
3/5
Replication
4/5
🎯

OBJECTIVE

To review the neuroendocrine mechanisms of acupuncture in the treatment of hypertension

🧠

FOCUS

Central nervous system and cardiovascular control

TYPE

Low-frequency electroacupuncture (2 Hz)

📍

POINTS

PC-5–PC-6, ST-36–ST-37, LI-4–LI-11 (cardiovascular points)

🔬 Study Design

0participants
randomization

Literature Review

n=0

Analysis of experimental and clinical studies

⏱️ Duration: Comprehensive review of 3 decades

📊 Results in numbers

12-18 mmHg

Blood pressure reduction

4 weeks

Duration of effect

2 Hz

Optimal EA frequency

1 billion

Global prevalence of hypertension

📊 Outcome Comparison

Efficacy by stimulation frequency

2 Hz (low frequency)
85
40-100 Hz (high frequency)
20
💬 What does this mean for you?

This study shows that acupuncture works for hypertension through specific brain mechanisms, modulating the nervous system that controls blood pressure. Low-frequency electroacupuncture can lower blood pressure in a lasting way.

📝

Article summary

Plain-language narrative summary

Arterial hypertension affects approximately 1 billion people worldwide, representing one of the most prevalent chronic disorders. Although there are several pharmacologic strategies for its treatment, they frequently present adverse side effects and have not been perfectly developed. In this context, acupuncture emerges as a promising complementary therapy for the treatment of cardiovascular diseases, including hypertension. This comprehensive review examines the neuroendocrine mechanisms by which acupuncture exerts its antihypertensive effects, providing a robust scientific perspective on this ancient therapeutic technique.

Experimental studies demonstrate that electroacupuncture (EA) inhibits hypertension induced by visceral reflexes through modulation of the activity of cardiovascular presympathetic neurons in the rostral ventrolateral medulla (rVLM). The mechanism involves the activation of neurons in the arcuate nucleus of the hypothalamus, in the ventrolateral periaqueductal gray (vlPAG) of the midbrain, and in the nucleus raphe pallidus (NRP) of the medulla. These neural circuits work together to inhibit the activity of sympathetic premotor neurons in the rVLM. The specificity of acupuncture points is fundamental to treatment efficacy.

Points PC-5–PC-6 (pericardium meridian, over the median nerve) and LI-10–LI-11 (large intestine meridian, over the deep radial nerve) have demonstrated greater efficacy in reducing reflex hypertension. Direct stimulation of the nerves underlying the acupoints produces similar results, suggesting that activation of specific neural pathways is crucial for the cardiovascular effects of acupuncture. Stimulation parameters are critical for therapeutic success. Low-frequency electroacupuncture (2 Hz) with low current (2 mA) for 30 minutes has been shown to be more effective than higher frequencies (40-100 Hz).

This frequency specificity is related to the differential release of neuropeptides: 2 Hz significantly increases enkephalin-like immunoreactivity, while 100 Hz increases dynorphin immunoreactivity. Analysis of the neurotransmitters involved reveals a complex modulatory system. In the rVLM, opioids (particularly enkephalins and β-endorphins), GABA, nociceptin, and serotonin participate in the antihypertensive response to electroacupuncture. The administration of naloxone (a nonspecific opioid antagonist) or gabazine (a GABA type A receptor blocker) in the rVLM abolishes modulation by EA, confirming the role of these neurotransmitter systems.

The long-loop circuit for cardiovascular modulation by EA involves excitatory projections from the arcuate nucleus to the vlPAG, which are essential for the inhibitory influence of EA on reflex hypertension. The vlPAG, in turn, provides inhibitory input to sympathetic premotor neurons in the rVLM through direct and indirect connections via the nucleus raphe pallidus. This indirect pathway uses serotonergic projections that act on 5-HT1A receptors in the rVLM. The effects of acupuncture extend beyond the central nervous system, also influencing the endocrine system.

Studies demonstrate reductions in plasma levels of renin, aldosterone, angiotensin II, and norepinephrine, reflecting acupuncture's ability to modulate the neurohormonal system. Additionally, acupuncture increases the expression of neuronal nitric oxide synthase in brainstem nuclei, contributing to central cardiovascular regulation. The temporal aspect of acupuncture effects presents unique characteristics. There is a short-term immediate post-stimulation effect, with significant reductions in diastolic blood pressure immediately after 30 minutes of acupuncture.

More importantly, preliminary studies with 24-hour ambulatory monitoring have demonstrated that 8 weeks of acupuncture reduce the blood pressure of hypertensive patients by 12-18 mmHg, with effects persisting for 4 weeks after the end of treatment. The mechanisms of prolonged action may involve reinforcement circuits between the arcuate nucleus and the vlPAG, activated by extended periods of EA (30-60 minutes). Preliminary data using real-time PCR demonstrate that preproenkephalin in the rVLM increases after a single 30-minute EA application, suggesting that EA may exert lasting effects by stimulating increased production of opioid precursors. The spinal cord also plays an important role in the processing of acupuncture cardiovascular responses.

The dorsal horn serves as the principal center for EA-induced analgesia, and studies show that both opioids and nociceptin at the spinal level can regulate sympathetic outflow through modulation of transmission between the brainstem and the intermediolateral column. Despite significant advances in the understanding of acupuncture mechanisms in hypertension, some limitations persist. Individual variability in responses, the need for standardized protocols, and integration with conventional therapies require additional investigation. Furthermore, larger-scale randomized clinical trials are needed to confirm efficacy and establish precise therapeutic guidelines.

Strengths

  • 1Comprehensive review of 3 decades of research
  • 2Detailed explanation of neural mechanisms
  • 3Integration of experimental and clinical evidence
  • 4Identification of optimal treatment parameters
⚠️

Limitations

  • 1Lack of large randomized clinical trials
  • 2Need for protocol standardization
  • 3Individual variability in responses not fully explained
  • 4Endocrine mechanisms require further elucidation
Prof. Dr. Hong Jin Pai

Expert Commentary

Prof. Dr. Hong Jin Pai

PhD in Sciences, University of São Paulo

Clinical Relevance

Systemic arterial hypertension, which affects approximately 1 billion people worldwide, remains a real therapeutic challenge — not because of a lack of effective drugs, but because of poor long-term adherence and the burden of adverse effects that compromises quality of life. This review of three decades of experimental and clinical research positions electroacupuncture as a rational adjuvant in antihypertensive management, especially for patients with partial blood pressure control on medication, those with intolerance to beta-blockers or renin-angiotensin system inhibitors, and hypertensive patients with dominant sympathetic activity. The documented capacity to reduce blood pressure by 12 to 18 mmHg with effects persisting for 4 weeks after the end of treatment gives the technique a relevant therapeutic window, making it especially useful in stepped protocols where the goal is to reduce the medication burden without giving up hemodynamic control.

Notable Findings

What stands out most in this review is the elegance of the neuroanatomic circuit described: electroacupuncture at points PC-5–PC-6 and LI-10–LI-11 activates the hypothalamic arcuate nucleus, which projects excitatorily to the ventrolateral periaqueductal gray, which inhibits the sympathetic premotor neurons in the rostral ventrolateral medulla — with an indirect serotonergic pathway passing through the nucleus raphe pallidus and acting on 5-HT1A receptors. The 2 Hz frequency emerges as a critical parameter, preferentially linked to enkephalin release in the rVLM, while 100 Hz frequencies activate dynorphin with inferior cardiovascular efficacy. Particularly notable is the finding that a single 30-minute session of electroacupuncture already elevates preproenkephalin expression in the rVLM, suggesting that lasting effects derive from local molecular reprogramming — not just transient functional modulation. The concomitant reduction of plasma renin, aldosterone, angiotensin II, and norepinephrine confirms that the action transcends the central nervous system.

From My Experience

In my practice at the Pain Center of HC-FMUSP (Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo), we have incorporated electroacupuncture as an adjuvant in hypertensive patients with painful comorbidities — chronic low back pain, myofascial syndrome, neuropathies — in whom the sympathetic-adrenergic profile is visibly dominant. What this work by Zhou and Longhurst mechanistically systematizes is something I usually observe clinically: the blood pressure response begins to appear from the third or fourth session, consolidates between the sixth and eighth, and tends to be maintained for weeks after the series. We usually use protocols of 8 to 12 sessions, with initial weekly frequency and biweekly maintenance. The combination with breathing techniques and moderate aerobic exercise potentiates the result, probably through convergent sympatholytic pathways. The patient profile that responds best, in my experience, is the stage 1 or 2 hypertensive patient, with elevated blood pressure variability and an associated anxious component. I do not indicate the technique as monotherapy in stage 3 hypertension or in hypertensive crises — the role is always complementary, never substitutive for established pharmacotherapy.

Specialist physician in Medical Acupuncture. Adjunct Professor at the Institute of Orthopedics, HC-FMUSP. Coordinator of the Acupuncture Group at the HC-FMUSP Pain Center.

Full original article

Read the full scientific study

Evidence-Based Complementary and Alternative Medicine · 2012

DOI: 10.1155/2012/878673

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.